Redx Pharma PLC
LSE:REDX
Income Statement
Earnings Waterfall
Redx Pharma PLC
Revenue
|
4.2m
GBP
|
Operating Expenses
|
-35.2m
GBP
|
Operating Income
|
-31m
GBP
|
Other Expenses
|
-2.2m
GBP
|
Net Income
|
-33.2m
GBP
|
Income Statement
Redx Pharma PLC
Sep-2015 | Mar-2016 | Sep-2016 | Mar-2017 | Sep-2017 | Mar-2018 | Sep-2018 | Mar-2019 | Sep-2019 | Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
30
N/A
|
31
+0%
|
0
-100%
|
0
N/A
|
3
N/A
|
4
+37%
|
6
+32%
|
7
+16%
|
10
+52%
|
14
+42%
|
20
+44%
|
19
-9%
|
13
-32%
|
4
-67%
|
|
Gross Profit | |||||||||||||||||||
Cost of Revenue |
(1)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Gross Profit |
(1)
N/A
|
(0)
+62%
|
0
N/A
|
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
3
N/A
|
4
+42%
|
0
N/A
|
0
N/A
|
0
N/A
|
4
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | |||||||||||||||||||
Operating Expenses |
(9)
|
(12)
|
(14)
|
(17)
|
(24)
|
(22)
|
(10)
|
(10)
|
(10)
|
(10)
|
(14)
|
(23)
|
(30)
|
(39)
|
(42)
|
(37)
|
(40)
|
(35)
|
|
Selling, General & Administrative |
(5)
|
0
|
(0)
|
0
|
(5)
|
(7)
|
(3)
|
(1)
|
(0)
|
(0)
|
(4)
|
(6)
|
(6)
|
(9)
|
(12)
|
(10)
|
(10)
|
(8)
|
|
Research & Development |
(5)
|
0
|
0
|
0
|
(8)
|
0
|
(6)
|
0
|
(6)
|
0
|
(10)
|
0
|
(24)
|
(31)
|
(44)
|
(28)
|
(32)
|
(29)
|
|
Depreciation & Amortization |
(0)
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(1)
|
0
|
(1)
|
(0)
|
0
|
(1)
|
0
|
0
|
|
Other Operating Expenses |
2
|
(12)
|
(14)
|
(17)
|
(11)
|
(16)
|
(2)
|
(9)
|
(3)
|
(10)
|
1
|
(17)
|
1
|
1
|
14
|
2
|
2
|
2
|
|
Operating Income |
(9)
N/A
|
(12)
-28%
|
(14)
-19%
|
(17)
-20%
|
7
N/A
|
8
+17%
|
(10)
N/A
|
(10)
-2%
|
(7)
+31%
|
(6)
+18%
|
(8)
-44%
|
(16)
-96%
|
(20)
-22%
|
(25)
-24%
|
(21)
+13%
|
(19)
+13%
|
(27)
-47%
|
(31)
-13%
|
|
Pre-Tax Income | |||||||||||||||||||
Interest Income Expense |
(0)
|
(0)
|
(0)
|
(2)
|
(4)
|
1
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(2)
|
(2)
|
0
|
(2)
|
1
|
1
|
1
|
|
Non-Reccuring Items |
1
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
|
Total Other Income |
0
|
0
|
0
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(2)
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(9)
N/A
|
(12)
-39%
|
(15)
-25%
|
(20)
-28%
|
2
N/A
|
8
+367%
|
(10)
N/A
|
(9)
+8%
|
(6)
+32%
|
(6)
+2%
|
(9)
-48%
|
(18)
-95%
|
(21)
-20%
|
(26)
-23%
|
(23)
+11%
|
(18)
+24%
|
(29)
-62%
|
(33)
-14%
|
|
Net Income | |||||||||||||||||||
Tax Provision |
1
|
0
|
(0)
|
1
|
(0)
|
(0)
|
1
|
3
|
2
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Income from Continuing Operations |
(8)
|
(12)
|
(16)
|
(19)
|
2
|
8
|
(9)
|
(7)
|
(4)
|
(6)
|
(9)
|
(18)
|
(22)
|
(26)
|
(24)
|
(18)
|
(29)
|
(33)
|
|
Net Income (Common) |
(8)
N/A
|
(12)
-48%
|
(16)
-29%
|
(19)
-23%
|
2
N/A
|
8
+399%
|
(9)
N/A
|
(7)
+26%
|
(4)
+34%
|
(6)
-38%
|
(9)
-54%
|
(18)
-95%
|
(22)
-20%
|
(26)
-23%
|
(19)
+30%
|
(18)
+3%
|
(29)
-61%
|
(33)
-14%
|
|
EPS (Diluted) |
-0.14
N/A
|
-0.19
-36%
|
-0.2
-5%
|
-0.2
N/A
|
0.01
N/A
|
0.06
+500%
|
-0.07
N/A
|
-0.05
+29%
|
-0.03
+40%
|
-0.04
-33%
|
-0.05
-25%
|
-0.08
-60%
|
-0.08
N/A
|
-0.1
-25%
|
-0.09
+10%
|
-0.06
+33%
|
-0.09
-50%
|
-0.1
-11%
|